Mariana Oncology
97 employees on LinkedIn · 9 known investors
Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue. Its pipeline targets challenging cancers with the goal of improving both treatment efficacy and patient experience.
Investors · 9
Access BiotechnologyNew York City
Atlas VentureCambridge · $500K – $1M
Nextech InvestZurich · $648K – $3.2M
Forbionreported · 2 sourcesNaarden
RA Capitalreported · 2 sourcesBoston
Also in the syndicate · 4
Deep Track CapitalleadEli LillyEli Lilly and CompanySurveyor Capital
Funding
SEC filings, press & company announcements$175M disclosed across 1 of 2 rounds · 2021–2023
- $175MSeries BSep 2023 · 3 sources
Deep Track Capital (lead), Forbion (lead), Access Biotechnology, Atlas Venture, Eli Lilly, Eli Lilly and Company, Nextech Invest, RA Capital Management, Surveyor Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Mariana Oncology went on to found or lead other companies.
In the news
Frequently asked questions
- What does Mariana Oncology do?
- Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue. Its pipeline targets challenging cancers with the goal of improving both treatment efficacy and patient experience.
- Who are Mariana Oncology's investors?
- Mariana Oncology's investors include Access Biotechnology, Atlas Venture, Nextech Invest, Forbion, RA Capital.
- How much funding has Mariana Oncology raised?
- Mariana Oncology has disclosed $175M raised across 1 of its 2 known rounds.